Skip to main content

Advertisement

SpringerLink
Log in

Triad of trichomegaly, alopecia and male-pattern hair growth during treatment with erlotinib in non-small-cell lung cancer

  • Case Report
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

Introduction

Description of the cutaneous side effects of erlotinib.

Materials

Report with images of a single case.

Methods

Case report and review of the literature.

Conclusion

Erlotinib is associated with significant cutaneous toxicity which should be recognised and managed appropriately.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Shepherd FA, Rodrigues Pereira J, Seymour L et al (2005) Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 353(2):123–132

    Article  CAS  PubMed  Google Scholar 

  2. Perez-Soler R, Saltz L (2005) Cutaneous adverse effects with HER1/EGFR-targeted agents: is there a silver lining? J Clin Oncol 23(22):5235–5246

    Article  PubMed  Google Scholar 

  3. Carser JE, Summers YJ (2006) Trichomegaly of the eyelashes after treatment with erlotinib in non-small-cell lung cancer. J Thorac Oncol 1(9):1040–1041

    Article  PubMed  Google Scholar 

  4. Gerber PA, Homey B (2008) Images in clinical medicine. Erlotinib-induced hair alterations. N Engl J Med 358(11):1175

    Article  CAS  PubMed  Google Scholar 

  5. Costa DB, Kobayashi S, Schumer ST (2007) Erlotinib-associated alopecia in a lung cancer patient. J Thorac Oncol 2(12):1136–1138

    Article  PubMed  Google Scholar 

  6. Segaert S, Van Cutsem E (2005) Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors. Ann Oncol 16(9):1425–1433

    Article  CAS  PubMed  Google Scholar 

  7. Lacouture ME, Lai SE (2006) The PRIDE syndrome. Br J Dermatol 155:852–854

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest statement

None.

Author information

Authors and Affiliations

  1. Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland

    P. Forde, C. Murphy, C. O’Sullivan & D. Carney

  2. Department of Medical Oncology, Cork University Hospital, Wilton, Cork, Ireland

    P. Forde

Authors
  1. P. Forde
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. O’Sullivan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Carney
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Forde.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Forde, P., Murphy, C., O’Sullivan, C. et al. Triad of trichomegaly, alopecia and male-pattern hair growth during treatment with erlotinib in non-small-cell lung cancer. Ir J Med Sci 180, 283–284 (2011). https://doi.org/10.1007/s11845-009-0458-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-009-0458-6

Keywords

Search

Navigation